Gerresheimer Stock in Freefall After Another Profit Warning – Is the Worst Over?
Gerresheimer cut its 2025 outlook after weak Q3 results, now expecting organic revenue to fall 2–4% and EBITDA margin to drop to 18.5–19%. Shares plunged 12% on Oct 9, hitting €33 and marking a year-to-date loss of over 50%. The company cited weak demand in cosmetics and oral liquid packaging. A BaFin probe into 2024 accounts and repeated guidance cuts have added pressure.
